This illustration provided by AstraZeneca depicts packaging for their medication Beyfortus. U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year. The Food and Drug Administration on Monday, July 17, 2023 approved the injection for infants and children up to 2 years old. (AstraZeneca via AP)
By Matthew Perrone
U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.
“Today’s approval addresses the great need for products to help reduce the impact of RSV disease on children, families and the health care system” said FDA's Dr. John Farley in a statement.
Last year, a surge in RSV cases flooded U.S. hospitals with wheezing children. There are no vaccines for babies yet, though Pfizer and other companies are working on them.
AstraZeneca’s drug, to be sold under the brand name Beyfortus, is a laboratory-made version of an antibody that helps the immune system fight off RSV. Under the FDA approval, babies — including preterm infants — can receive a single injection to protect against their first season of RSV, which typically lasts about five months. Children up to age 2 can receive another dose to protect them during their second season facing the virus.
Beyfortus, which will be marketed in the U.S. by Sanofi, is already approved in Canada, Europe and the U.K. Sanofi did not immediately announce the U.S. price of the treatment.
FDA officials approved the drug based on three studies showing Beyfortus reduced the risk of RSV infection between 70% and 75% among infants and children 2 and younger.
Advisers to the Centers for Disease Control and Prevention will meet early next month to recommend exactly who should get the drug.
A similar antibody drug won FDA approval more than 20 years ago, but it’s only recommended for high-risk babies and requires monthly injections. Pediatricians say the drug is underutilized and they expect the longer-lasting effect of AstraZeneca's shot to improve uptake.
In the U.S., about 58,000 children younger than 5 are hospitalized for RSV each year and several hundred die.
After decades of setbacks for RSV research, drugmakers have made big strides this year, launching the first vaccines against the virus. In May, the FDA approved two RSV vaccines for older adults from GlaxoSmithKline and Pfizer. In August, the FDA is expected to make a decision on approving Pfizer’s vaccine for pregnant women, with the aim of passing along protection to their newborns.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
Andrew Chanin, CEO of investment management firm ProcureAM, joined Cheddar to break down the many industries in the space economy and discuss what trends are driving the most growth. "Right now there's been so much media focus on space tourism. Why? Because last year it really debuted itself to the world," he said. "However it's less than 1 percent of the overall space economy, and there are many other parts of space which are actually driving this area."
Plastic has become the face of global pollution. To date, humans have produced 8.3 billion metric tons of it. Once discarded, plastic doesn’t biodegrade. Instead, it fragments into microplastics smaller than the size of a sesame seed and further into nanoplastics.
These tiny particles of plastic end up everywhere, deep in the ice of Antarctic glaciers or even inside our bodies.
So how much plastic is inside of us? And what does it mean for our health? Let’s find out.
Catching you up on what you Need to Know on Mar 29, 2022, with updates on the snow squall in Pennsylvania that caused a pileup killing three, the teacher's strike in Sacramento heading into week two, Walmart no longer selling tobacco products in select stores, and what meme stocks are up to this week.
Catching you up on what you Need to Know on Mar 28, 2022, with peace talks resuming in Ukraine as early as today, Colorado wildfires causing evacuations, Shanghai, China, ramping up restrictions once again, the Oscars debacle between Will Smith and Chris Rock, and more.
The U.S. market value of the plant-based food industry reached an all-time high last year. According to a new report from the Plant Based Food Association, retail sales of plant-based foods reached $7.4 billion, but questions are arising over whether the industry can sustain the levels of growth it had in the past few years. Julie Emmett, senior director of marketplace development at the Plant Based Food Association, joined Cheddar News' Closing Bell to discuss.
Bowery Farming's vertical growing process allows it to cultivate 13 types of greens — and now, strawberries — in a sustainable way that's also faster than traditional farming. Bowery focuses on sustainability from start to finish, using unique technology to provide plants with what they need at the right time while eliminating waste and cutting down on carbon dioxide emissions. Katie Seawell, Chief Commercial Officer of Bowery Farming, joins Closing Bell to discuss the company's vertical farming process, sustainability focus, fixing the food supply chain, and more.
Nexii, a company based in Canada, is getting some big backing for its sustainable, low-carbon concrete alternative. CEO Stephen Sidwell, joined Cheddar News to talk about the initiatives his company is taking to tackle climate change and scaling up production to meet demand. "Most people don’t realize it, but buildings are the number one contributor to CO2 emissions," he said. "So that's really what we're attacking, the overall CO2 emissions."
Catching you up on what you need to know on March 25, 2022, with Ukrainian forces retaking Kyiv, 300 deaths reported from the bombing of a theater used as a shelter in Mariupol, U.S. regulators ditch a climate review of natural gas projects, the 94th Academy Awards, and more.
New York City Mayor Eric Adams has announced the removal of the mask mandate in school and day-care centers for children under 5. If COVID-19 cases remain low, this change will take place on April 4th. Syra Madad, an infectious disease epidemiologist, joins Cheddar News to discuss.
